All News

Medical schools are working to bring AR and VR technology into the classroom. Could pharmacy do the same?

Obesity has been considered a risk factor for severe acute respiratory illness, including more severe cases of the flu, but a recently-published study found that weight may not be associated with increased illness severity.

Pharmacists are exposed to increasing job stress. Why does that matter?

March is National Sleep Awareness Month, and pharmacists can help patients get their rest.

News and internet forums are filled with ride-sharing drivers who have taken patients to the hospital or the doctors.

New data may support the potential of achieving clinical benefits by using CAR T cells in patients with glioblastoma.

First Abbreviated New Drug Application filed for sofosbuvir (Sovaldi).

Younger patients with IBD may be at a high risk of experiencing a heart attack.

Many small health start-ups are leveraging digital health and telemedicine services to provide patient coaching. A new study from one company demonstrates that users could see as much as a 0.8% reduction in A1c.

FDA approves shorter administration periods and new dosing options for nivolumab (Opdivo).

Research into gene variants may improve targeted treatments for pancreatic cancer.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The American College of Physicians (ACP) recently issued new guidelines aimed at assisting clinicians in making decisions about targets when using pharmacologic therapy in adults with type 2 diabetes.

The risk of HIV Infection may increase during and after pregnancy, a new study suggests.

The aging HIV population presents challenges to health care providers.

Clinicians should personalize patient's goals for blood sugar control in type 2 diabetes.

Officials with the FDA have approved a supplemental new drug application (sNDA) to expand the use of lurasidone HCl (Latuda, Sunovion) to include the treatment of bipolar depression in pediatric patients (10 to 17 years of age).

The online retailing giant has its own brand of nonprescription drugs. Can it compete?

Talk to your patients about alternative therapy with these tips

The past decade has seen a large change in the field of pharmacy, with many companies changing the landscape with new mergers and acquisitions.

Looking to get their data into clinician hands, Higi has teamed up with Rush to get their data into institutions using Epic's EHRs.

More smart inhalers are coming to the US market and pharmacists may see them soon.

Officials with the FDA have approved ibalizumab-uiyk (Trogarzo, TaiMed Biologics), the first antiretroviral medication for adults with HIV who cannot be successfully treated with other therapies.

Officials with the FDA have approved ibalizumab-uiyk (Trogarzo, TaiMed Biologics), the first antiretroviral medication for adults with HIV who cannot be successfully treated with other therapies.

Over the years, a number of landmark clinical studies on the management of AF have been published, sharping how patients are treated. Here are 4 that every pharmacist should know about.

Getting to your medical appointment can be a pain, so why not call on Uber or Lyft? Well, soon you'll get your chance.

A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.

Mylan will reduce the wholesale acquisition costs of Smyfi Lo and Cimduo, which are both combination therapies for HIV.

Targeting an energy-related molecule could prevent the onset of autoimmune diseases.